2nd World Hepatitis Congress

Hepatitis Congress 2019

Theme: Discovering and Redesigning Treatment for Hepatitis

2nd World Hepatitis Congress will be held in Paris, France on September 23-24, 2019. The main theme of Hepatitis Conference is “Discovering and Redesigning Treatment for Hepatitis”. This Hepatitis Congress gives an unfathomable stage for the get-together of conspicuous teachers, researchers, students, and agents to exchange new considerations. It gives the disciplinary manual for researchers, experts and mentors to show and look at the most recent headways, examples and concerns, useful troubles experienced and the results completed in the field of hepatitis. It centers on a wide cluster of points that incorporate the accompanying: Acute Hepatitis, Alcoholic Hepatitis, Autoimmune Hepatitis, Chronic Hepatitis, Giant Cell Hepatitis, Parasitic Hepatitis, Drug-Induced Hepatitis and Advance in Hepatitis Testing. Hepatitis 2019 Conference is to bring top experts together and delegates for an in-depth discussion on Hepatitis and Liver diseases. To create awareness for both rural and urban population about liver disease it should be diagnosed at early stages. The importance of this conference is to update, clinically relevant audience regarding the evidence supporting current clinical practices in hepatitis.

Hepatitis 2019 welcomes Medical Hepatologist specialists, pathologists, Liver oncologists, Surgeons, Research scholars, Industrial professionals and Student delegates from biomedical and healthcare sectors to be a part of it. This International Conference aims to bring together academicians, doctors, researchers and industry personnel to meet, discuss and share innovations, research, and ideas on liver treatments for a greater development and more effective treatments.

Session 1: Hepatitis

Hepatitis arises due to the inflammation in liver tissues due to infection by virus which can harm the organ that may further leads to cirrhosis, fibrosis and liver cancer. The 5 main hepatitis viruses are referred to as types A, B, C, D and E. They are of extreme concern due to the problem of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, the most common and Acute which causes in children is Hepatitis A. Types B and C clue to chronic disease in hundreds of millions of people and composed of the most common cause of liver cirrhosis and cancer. The three types of hepatitis are Toxic, Alcohol and viral Hepatitis. Symptoms of Hepatitis are fever, fatigue, loss of appetite. Treatment options are determined by which type of hepatitis is present and whether the infection is acute or chronic.

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Session 2: Alcoholic Hepatitis

Alcoholic hepatitis (AH) in its extreme frame has one month mortality as high as half. Many people who create Alcoholic hepatitis are men however ladies are at higher danger of creating and its difficulties likely auxiliary to high muscle to fat ratio and contrasts in liquor metabolism. Other contributing elements incorporate more youthful age <60, fling design drinking, poor dietary status, corpulence and hepatitis C co-disease. It is assessed that as much as 20% of individuals with Alcoholic hepatitis are likewise contaminated with hepatitis C.

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Session 3: Hepatitis B & Hepatitis C

It's caused by the hepatitis B infection. Around 2 billion people on the planet have confirmation of past or introduce hepatitis B, and 2.2 million individuals in the U.S. are constantly tainted with hepatitis B. Damage to the liver by hepatitis B infection is caused by the body's resistant reaction as the body endeavours to kill the infection. Hepatitis C is an irresistible ailment caused by the hepatitis C infection (HCV) that basically influences the liver. During the underlying contamination individuals regularly have gentle or no side effects. Occasionally a fever, dim pee, stomach torment, and yellow tinged skin happen.

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Session 4: Pancreatitis

Pancreatitis is inflammation in pancreas. Pancreatitis can be an acute (short-term) or chronic (long-term) condition. Acute pancreatitis is a sudden inflammation that lasts for a short time. It may lead from mild discomfort to a life-threatening illness. Most people with acute pancreatitis recover completely after the attainment of right treatment. Chronic pancreatitis often happens after an episode of acute pancreatitis. Heavy alcohol consumption is major cause which leads to chronic pancreatitis, it may not show symptoms for many years, but then the person may suddenly develop severe pancreatitis symptoms such as swollen and tender abdomen, upper abdominal pain, nausea, increased heart rate. Other disorders of pancreas include endocrine and exocrine syndromes.

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Session 5: Hepatitis Epidemiology

It is evaluated that 143 million individuals (2%) of individuals internationally are living with ceaseless. Around 3– 4 million individuals are contaminated every year, and more than 350,000 individuals bite the dust yearly from hepatitis C related sicknesses. Amid 2010 it is evaluated that 16,000 individuals kicked the bucket from intense contaminations while 196,000 passing’s happened from liver malignancy auxiliary to the disease. Rates are high (>3.5% populace contaminated) in Central and East Asia, North Africa and the Middle East, they are moderate (1.5%-3.5%) in South and Southeast Asia, sub-Saharan Africa, Andean, Central and Southern Latin America, Caribbean, Oceania, Australasia and Central, Eastern and Western Europe; and they are low (<1.5%) in Asia-Pacific, Tropical Latin America and North America.

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Session 6: Hepatitis Immunology & Vaccine Biology

Hepatitis B is a genuine ailment caused by an infection that assaults the liver. The infection, which is called hepatitis B infection (HBV) can cause long lasting disease, cirrhosis (scarring) of the liver, liver tumour, liver disappointment and demise. Hepatitis B antibody is accessible for all age gatherings to forestall HBV disease. The present utilized hepatitis B immunizations are made artificially (i.e. they don't contain blood items) and have been accessible in the U.S. since 1986. You can't get hepatitis B from the antibody. Take in more. This sheltered and powerful immunization is suggested for all new born children during childbirth and for youngsters up to 18 years.

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Session 7: HCV/HIV Co-Infection

In HIV–HCV co-infected patients, the hepatitis C (HCV) viral load is higher than in HCV-mono-infected patients in both the plasma and liver tissue. Patients who are HIV-positive are commonly co-infected with HCV due to shared routes of transmission: percutaneous exposure to blood, sexual intercourse and from a mother to her infant. Infection with HCV can be asymptomatic, self-limiting, or progress to cirrhosis or cancer.

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Session 8: Herbal Medicines & Liver Diseases

Homegrown medications have turned out to be progressively famous and their utilization is across the board. Authorizing controls and pharmacovigilance with respect to homegrown items are as yet inadequate and obvious verification of their viability in liver illnesses is meager. All things considered, various herbals indicate promising movement including silymarin for antifibrotic treatment, Phyllanthus amarus in unending hepatitis B, glycyrrhizin to treat perpetual viral hepatitis and various homegrown blends from China and Japan that merit testing in proper investigations.

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Session 9: Diabetic Exposure & Liver Cancer

Type 2 diabetes and liver Cancer goes hand in hand with the mechanism and complications. The risk of liver cancer is higher in people with Type 2 Diabetes than people with Diabetes Type 1. An advance feasible natural instrument for the affiliation between diabetes and liver cancer is that up to 80% of individuals with diabetes type 2 are thought to have non-alcoholic fatty liver illness which increments hazard of cirrhosis and consequent Hepatocellular Carcinoma (HCC).

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Session 10: Prevention & Treatment for Hepatitis

Hepatitis A, B, C and E virus will resolve on their own by hepatitis infections over several weeks or months. But severe cases of acute hepatitis B can be treated with antiviral drugs such as lamivudine. Chronic hepatitis B and C infections which do not get better on their own after a few months may be treated with antiviral medications such as pegylated interferon injections or oral antivirals such as lamivudine for hepatitis B or ribavirin for hepatitis C. However, ribavairin must be taken with peginterferon in order for it to be an effective treatment against hepatitis C. Although there is no vaccine for hepatitis D, the disease can still be prevented by vaccinating against hepatitis B. Liver transplants may be necessary if the liver is severely damaged.

Hepatitis Conference | Pancreatic Conference | Liver Conference | Liver Disease Conference | Hepatitis Meeting | Hepatology Conference

Introduction:

Hepatitis suggests a searing condition of the liver. It is for the most part caused by a viral sickness, yet there are other possible explanations behind hepatitis. Hepatitis is an overall restorative issue impacting more than 170 million people the world over. Hepatitis C is a principle wellspring of end-mastermind liver infirmity and hepatocellular carcinoma. The transcendence of viral hepatitis changes from region to area yet is all things considered higher in Middle Eastern countries. Hepatitis B can be checked by vaccination, once tainted a man can make dependable endless malady happening into extraordinary liver damage. Hepatitis C is most hazardous of among each one of the sorts of hepatitis as 80% of the hepatitis C sullied patients get unendingly corrupted. Around 150 million people are corrupted with hepatitis C worldwide and 350,000 people fail horrendously every year.

Scope:

Chronic infection with hepatitis C virus (HCV) is the leading cause of cirrhosis and the most common indication for liver transplantation in many countries throughout the world. The most significant factors leading to fibrosis progression in patients with chronic HCV infection include the degree of inflammation present on liver biopsy and on-going alcohol use. Patients with cirrhosis secondary to chronic HCV infection are at increased risk for developing hepatocellular carcinoma (HCC). Achieving a sustained biological response after treatment with interferon, with or without ribavirin is associated with a reduced risk for the development of cirrhosis and (Hepatocellular Carcinoma (HCC) and prolonged survival.

Global Business & Research Value on Hepatitis:

The predominance of the disease, new profitable medications, moderately lesser time of treatment from previously, and rising government financing, can drive the hepatitis C tranquillize showcase. The absence of mindfulness and data about HCV and treatment cost of ailment can impact the hepatitis C showcase. Over the most recent couple of years, a few new medications have been propelled in the market which has the enormous achievement and caught the greatest piece of the overall industry of the hepatitis C advertise.

Global Universities:

USA:

Duke University School of Medicine

Harvard Medical School

Johns Hopkins School of Medicine

Emory University School of Medicine

Yale School of Medicine

Baylor College of Medicine

Washington University School of Medicine

Mayo Clinic College of Medicine

Wayne State University School of Medicine

University of Massachusetts Medical School

Europe:

Catholic University of Valencia

Complutense University of Madrid

International University of Catalonia

Miguel Hernandez University

Pompeu Fabra University

Rovira i Virgili University

The Universitat Oberta de Catalunya

The University of Barcelona

Universidad Santiago de Compostela 

University of Vienna

Vienna University of technology

Asia:

International University - Cambodia

University of Health Sciences - Cambodia

University of Puthisastra

Akaki Tsereteli State University

David Agmashenebeli University of Georgia

Tbilisi State Medical University

Hashemite University

Jordan University of Science and Technology

Mutah University

Nanyang Technological University

National University of Singapore

Mordovian Ogarev State University

Global Funding Bodies:

Biotechnology and Biological Sciences Research Council

Bill & Melinda Gates Foundation

The Royal Society

The Gatsby Charitable Foundation

European Molecular Biology Organisation

European Research Council

European Science Foundation

Public Health Agency of Canada

Future Scope of Hepatitis:

Viral hepatitis has risen as a noteworthy general medical issue all through the world influencing a few a huge number of individuals Viral hepatitis is a reason for impressive dreariness and mortality in the human populace, both from intense disease and ceaseless squeal, which incorporate, on account of hepatitis B, C and D, interminable dynamic hepatitis and cirrhosis. Hepatocellular carcinoma which is one of the ten most regular malignancies worldwide is nearly connected with hepatitis B, and at any rate in a few districts of the world with hepatitis C infection. Immunization for hepatitis B infection (HBV) contamination and treatment for perpetual hepatitis B, while viable for essential counteractive action and control of the malady, still have their restrictions. Worldwide scope of HBV vaccination needs change. A few patient populaces are noted to have problematic seroprotective rates after HBV immunization. There are as of now a few potential new immunizations experiencing creature and human investigations, most prominently antibodies containing resistant stimulatory DNA arrangements.

Conclusion:

Hepatitis is an aggravation of the liver tissue. Hepatitis might be brief (intense) or long haul (ceaseless) contingent upon whether it goes on for not exactly or over a half year. Hepatitis A, B, and D are preventable with inoculation. Drugs might be utilized to treat perpetual instances of viral hepatitis. Disease with the hepatitis C infection (HCV) is an essential rising general medical problem for both created and creating countries; an expected 185 million individuals worldwide have been tainted with HCV. A continuous increment in the measurements demonstrated that Hepatitis is as of late broad sickness and may assault higher check of the populace. Legitimate preventive measures can keep away from the incurrence of the malady. Hepatitis B and D are unending and require appropriate treatment choices.

References:

https://www.marketresearchfuture.com/reports/hepatitis-c-drugs-market-2487

https://www.zionmarketresearch.com/news/hepatitis-c-drug-market

https://www.persistencemarketresearch.com/market-research/hepatitis-c-treatment-market.asp

https://www.futuremarketinsights.com/reports/hepatitis-b-therapeutics-market

  • Hepatitis
  • Alcoholic Hepatitis
  • Hepatitis B & Hepatitis C
  • Pancreatitis
  • Hepatitis Epidemiology
  • Hepatitis Immunology & Vaccine Biology
  • HCV/HIV Co-Infection
  • Herbal Medicines & Liver Diseases
  • Diabetic Exposure & Liver Cancer
  • Prevention & Treatment for Hepatitis

7 Organizing Committee Members

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner